Table 3. Race and ethnicity in relation to breast cancer specific survival by estrogen receptor status and five-year diagnosis group.
Estrogen Receptor Positive | Estrogen Receptor Negative | |||||||
---|---|---|---|---|---|---|---|---|
Diagnosis Years: | Cohort | Five-Year Breast Cancer Specific Survival* |
Hazard Ratio (95% Confidence Interval) |
Cohort | Five-Year Breast Cancer Specific Survival* |
Hazard Ratio (95% Confidence Interval) |
||
N | % | N | % | |||||
1990–94: | ||||||||
White Non-Hispanic | 44507 | 88.6 | .89 | 1.0 | 12954 | 79.7 | .77 | 1.0 |
Hispanic White | 2261 | 4.5 | .87 | 1.3 (1.1–1.4) | 1027 | 6.3 | .75 | 1.1 (1.0–1.3) |
Black | 3244 | 6.5 | .80 | 2.0 (1.8–2.2) | 2190 | 13.5 | .67 | 1.6 (1.4–1.7) |
American Indian/ Alaska Native |
206 | 0.4 | .84 | 1.6 (1.1–2.4) | 90 | 0.5 | .75 | 1.2 (0.8–1.8) |
1995–99: | ||||||||
White Non-Hispanic | 60132 | 87.8 | .92 | 1.0 | 15726 | 78.0 | .78 | 1.0 |
Hispanic White | 3296 | 4.8 | .89 | 1.4 (1.3–1.6) | 1406 | 7.0 | .73 | 1.3 (1.2–1.5) |
Black | 4723 | 6.9 | .84 | 2.1 (2.0–2.3) | 2861 | 14.2 | .69 | 1.5 (1.4–1.7) |
American Indian/ Alaska Native |
344 | 0.5 | .87 | 1.7 (1.3–2.3) | 157 | 0.8 | .67 | 1.7 (1.3–2.2) |
2000–04: | ||||||||
White Non-Hispanic | 133662 | 85.7 | .92 | 1.0 | 32684 | 74.4 | .79 | 1.0 |
Hispanic White | 9173 | 5.9 | .90 | 1.4 (1.3–1.5) | 3599 | 8.2 | .75 | 1.2 (1.1–1.3) |
Black | 12288 | 7.9 | .85 | 2.1 (2.0–2.2) | 7423 | 16.9 | .69 | 1.6 (1.5–1.7) |
American Indian/ Alaska Native |
715 | 0.5 | .90 | 1.4 (1.1–1.8) | 236 | 0.5 | .76 | 1.2 (0.9–1.6) |
2005–09: | ||||||||
White Non-Hispanic | 152926 | 82.5 | .92 | 1.0 | 32680 | 70.4 | .80 | 1.0 |
Hispanic White | 14305 | 7.7 | .91 | 1.3 (1.2–1.4) | 5021 | 10.2 | .78 | 1.2 (1.1–1.3) |
Black | 17198 | 9.3 | .86 | 2.0 (1.9–2.1) | 9237 | 18.8 | .73 | 1.5 (1.4–1.6) |
American Indian/ Alaska Native |
946 | 0.5 | .89 | 1.6 (1.3–1.9) | 292 | 0.6 | .75 | 1.4 (1.1–1.8) |